BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7913911)

  • 1. Polymorphisms of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease.
    Miettinen HE; Korpela K; Hämäläinen L; Kontula K
    Hum Genet; 1994 Aug; 94(2):189-92. PubMed ID: 7913911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme and apolipoproteins genes polymorphism in coronary artery disease.
    Mansur AP; Annicchino-Bizzacchi J; Favarato D; Avakian SD; César LA; Ramires JA
    Clin Cardiol; 2000 May; 23(5):335-40. PubMed ID: 10803441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability gene effects of DNA polymorphisms at the apo B, apo A I/C III and apo E loci on serum lipids: the Cardiovascular Risk in Young Finns Study.
    Porkka KV; Taimela S; Kontula K; Lehtimäki T; Aalto-Setälä K; Akerblom HK; Viikari JS
    Clin Genet; 1994 Mar; 45(3):113-21. PubMed ID: 7913004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic risk factors and ischaemic cerebrovascular disease: role of common variation of the genes encoding apolipoproteins and angiotensin-converting enzyme.
    Aalto-Setälä K; Palomäki H; Miettinen H; Vuorio A; Kuusi T; Raininko R; Salonen O; Kaste M; Kontula K
    Ann Med; 1998 Apr; 30(2):224-33. PubMed ID: 9667803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease.
    Ordovas JM; Civeira F; Genest J; Craig S; Robbins AH; Meade T; Pocovi M; Frossard PM; Masharani U; Wilson PW
    Atherosclerosis; 1991 Mar; 87(1):75-86. PubMed ID: 1678604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein B, apolipoprotein E, and angiotensin-converting enzyme polymorphisms in 2 Italian populations at different risk for coronary artery disease and comparison of allele frequencies among European populations.
    Corbo RM; Scacchi R; Mureddu L; Mulas G; Castrechini S; Rivasi AP
    Hum Biol; 1999 Dec; 71(6):933-45. PubMed ID: 10592684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene.
    Rodríguez-Pérez JC; Rodríguez-Esparragón F; Hernández-Perera O; Anabitarte A; Losada A; Medina A; Hernández E; Fiuza D; Avalos O; Yunis C; Ferrario CM
    J Am Coll Cardiol; 2001 May; 37(6):1536-42. PubMed ID: 11345362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoproteins B and E, and angiotensin I-converting enzyme (ACE) genetic polymorphisms in Italian women with coronary artery disease (CAD) and their relationships with plasma lipid and apolipoprotein levels.
    Corbo RM; Vilardo T; Mantuano E; Ruggeri M; Gemma AT; Scacchi R
    Clin Genet; 1997 Aug; 52(2):77-82. PubMed ID: 9298741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin system gene polymorphisms and premature coronary heart disease.
    Sekuri C; Cam FS; Ercan E; Tengiz I; Sagcan A; Eser E; Berdeli A; Akin M
    J Renin Angiotensin Aldosterone Syst; 2005 Mar; 6(1):38-42. PubMed ID: 16088850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease.
    Viitanen L; Pihlajamäki J; Halonen P; Lehtonen M; Kareinen A; Lehto S; Laakso M
    Atherosclerosis; 2001 Jul; 157(1):57-64. PubMed ID: 11427204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein A-I gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apo A-I and HDL-cholesterol concentration.
    Wile DB; Barbir M; Gallagher J; Myant NB; Ritchie CD; Thompson GR; Humphries SE
    Atherosclerosis; 1989 Jul; 78(1):9-18. PubMed ID: 2569310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of genetic polymorphisms of apolipoprotein E, angiotensin converting enzyme, apolipoprotein B-100, and glycoprotein IIIa and early-onset coronary heart disease.
    Nassar BA; Dunn J; Title LM; O'Neill BJ; Kirkland SA; Zayed E; Bata IR; Cantrill RC; Johnstone J; Dempsey GI; Tan MH; Breckenridge WC; Johnstone DE
    Clin Biochem; 1999 Jun; 32(4):275-82. PubMed ID: 10463820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme DD genotype and cardiovascular disease in heterozygous familial hypercholesterolemia.
    O'Malley JP; Maslen CL; Illingworth DR
    Circulation; 1998 May; 97(18):1780-3. PubMed ID: 9603531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population genetics of apolipoproteins A-IV, E, and H, and the angiotensin converting enzyme (ACE): associations with lipids, and apolipoprotein levels in American Samoans.
    Crews DE; Fitton LJ; Kottke BA; Kamboh MI
    Am J Phys Anthropol; 2004 Aug; 124(4):364-72. PubMed ID: 15252864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E gene promoter (-219G/T) polymorphism is associated with premature coronary heart disease.
    Viitanen L; Pihlajamäki J; Miettinen R; Kärkkäinen P; Vauhkonen I; Halonen P; Kareinen A; Lehto S; Laakso M
    J Mol Med (Berl); 2001 Dec; 79(12):732-7. PubMed ID: 11862316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA polymorphisms of apolipoprotein A-I/C-III and insulin genes in familial hypertriglyceridemia and coronary heart disease.
    Aalto-Setälä K; Kontula K; Sane T; Nieminen M; Nikkilä E
    Atherosclerosis; 1987 Jul; 66(1-2):145-52. PubMed ID: 3115275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease.
    Paulweber B; Friedl W; Krempler F; Humphries SE; Sandhofer F
    Atherosclerosis; 1988 Oct; 73(2-3):125-33. PubMed ID: 2903749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study.
    Marian AJ; Safavi F; Ferlic L; Dunn JK; Gotto AM; Ballantyne CM
    J Am Coll Cardiol; 2000 Jan; 35(1):89-95. PubMed ID: 10636265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study.
    Marshall HW; Morrison LC; Wu LL; Anderson JL; Corneli PS; Stauffer DM; Allen A; Karagounis LA; Ward RH
    Circulation; 1994 Feb; 89(2):567-77. PubMed ID: 8313545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.